Docket Room
A 4550·NJ·house

Requires health benefits coverage for buprenorphine and buprenorphine/naloxone for pain treatment without step therapy or fail-first protocols.

In CommitteeFiled Mar 10, 2026
Sponsor: Murphy, Carol A.
Latest Action

Introduced First Reading Assembly Referred to AFI

Mar 10, 2026

Summary

The bill mandates that all New Jersey health insurance contracts—including hospital, medical, HMO, individual, group, and small‑employer plans—must pay for buprenorphine or buprenorphine/naloxone when prescribed for pain. These plans cannot require step‑therapy or fail‑first protocols before covering the medication. The requirement applies to contracts issued or renewed after the law’s effective date.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Share

Track this bill

Get real-time alerts when A 4550 changes status, plus AI-powered summaries and stage predictions.

Sign up free
Docket Room · Nonpartisan legislative tracking
Docket Room IntelligencePro

Ask about your legislation

I can analyze your tracked bills, upcoming hearings, and recent changes.

AI-generated · Nonpartisan · Not legal advice